Bank of America Corp DE purchased a new stake in Ventas, Inc. (NYSE:VTR - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 4,396,344 shares of the real estate investment trust's stock, valued at approximately $390,395,000. Bank of America Corp DE owned about 0.86% of Ventas as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of VTR. Dynamic Wealth Strategies LLC purchased a new stake in shares of Ventas during the first quarter worth approximately $25,000. Silvant Capital Management LLC purchased a new stake in Ventas in the second quarter valued at $28,000. Meeder Asset Management Inc. acquired a new stake in shares of Ventas in the 2nd quarter valued at about $30,000. Elyxium Wealth LLC purchased a new position in shares of Ventas during the fourth quarter worth approximately $33,000. Finally, Reflection Asset Management purchased a new position in Ventas during the 4th quarter worth $34,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on VTR. Jefferies Financial Group began coverage on shares of Ventas in a research note on Tuesday. They issued a "buy" rating and a $102.00 price objective on the stock. Cantor Fitzgerald lifted their price objective on Ventas from $97.00 to $102.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. Royal Bank Of Canada upped their price target on shares of Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. Mizuho increased their price objective on Ventas from $98.00 to $104.00 and gave the company an "outperform" rating in a research note on Wednesday, July 22nd. Finally, The Goldman Sachs Group restated a "buy" rating and set a $110.00 target price on shares of Ventas in a research report on Tuesday, May 19th. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $99.11.
Get Our Latest Report on Ventas
Ventas Trading Down 0.7%
Shares of VTR opened at $88.49 on Wednesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The stock has a 50-day moving average price of $92.72 and a 200 day moving average price of $88.01. The company has a market capitalization of $45.39 billion, a P/E ratio of 163.86, a P/E/G ratio of 3.48 and a beta of 0.70. Ventas, Inc. has a one year low of $66.54 and a one year high of $101.60.
Ventas (NYSE:VTR - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. The business had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business's revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 EPS. Sell-side analysts forecast that Ventas, Inc. will post 3.89 EPS for the current fiscal year.
Ventas Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th will be issued a $0.52 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas's dividend payout ratio (DPR) is 385.19%.
Ventas Company Profile
(
Free Report)
Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.
The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.
Ventas serves major healthcare and life science markets in the United States and Canada.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ventas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.
While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.